M
Mohan Srinivasan
Researcher at Bristol-Myers Squibb
Publications - 100
Citations - 4310
Mohan Srinivasan is an academic researcher from Bristol-Myers Squibb. The author has contributed to research in topics: Monoclonal antibody & Antibody. The author has an hindex of 24, co-authored 98 publications receiving 4016 citations. Previous affiliations of Mohan Srinivasan include Princeton University & Medarex.
Papers
More filters
Patent
Human monoclonal antibodies to programmed death ligand 1 (pd-l1)
Korman Alan J,Selby Mark J,Changyu Wang,Mohan Srinivasan,David Passmore,Haichun Huang,Haibin Chen +6 more
TL;DR: In this paper, isolated monoclonal antibodies particularly human antibody that specifically bind to PD-L1 with high affinity are provided. And methods for detecting PDL1, as well as methods for treating various diseases, including cancer and infectious diseases, using anti-PDL1 antibodies.
Journal ArticleDOI
Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells.
Mark J. Selby,John J. Engelhardt,Michael Quigley,Karla A. Henning,Timothy Chen,Mohan Srinivasan,Alan J. Korman +6 more
TL;DR: Data suggest that anti-CTLA-4 promotes antitumor activity by a selective reduction of intratumoral Tregs along with concomitant activation of Teffs.
Journal ArticleDOI
In vitro characterization of the anti-PD-1 antibody nivolumab, BMS-936558, and in vivo toxicology in non-human primates.
Changyu Wang,Kent B. Thudium,Minhua Han,Xi-Tao Wang,Haichun Huang,Diane Feingersh,Candy Garcia,Yi Wu,Michelle Kuhne,Mohan Srinivasan,Sujata Singh,Susan Wong,Neysa Garner,Heidi N. Leblanc,R. Todd Bunch,Diann Blanset,Mark J. Selby,Alan J. Korman +17 more
TL;DR: In vitro assays demonstrated the ability of nivolumab to potently enhance T-cell responses and cytokine production in the mixed lymphocyte reaction and superantigen or cytomegalovirus stimulation assays, and no in vitro antibody-dependent cell-mediated or complement-dependent cytotoxicity was observed with the use of n ivolumAB and activated T cells as targets.
Journal ArticleDOI
Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor
Kevin M. Cox,Jason D. Sterling,Jeffrey T. Regan,John R. Gasdaska,Karen K Frantz,Charles G. Peele,Amelia Black,David Passmore,Cristina Moldovan-Loomis,Mohan Srinivasan,Severino Cuison,Pina M. Cardarelli,Lynn F. Dickey +12 more
TL;DR: The expression of human mAbs in the small aquatic plant Lemna minor offers several advantages for manufacturing therapeutic proteins free of zoonotic pathogens and had better antibody-dependent cell-mediated cytotoxicity and effector cell receptor binding activities than mAbs expressed in cultured Chinese hamster ovary (CHO) cells.
Journal ArticleDOI
Production of human monoclonal antibody in eggs of chimeric chickens
Lei Zhu,Marie-Cecile van de Lavoir,Jenny Albanese,David O. Beenhouwer,Pina M. Cardarelli,Severino Cuison,David F Deng,Shrikant Deshpande,Jennifer H. Diamond,Lynae Green,Edward L. Halk,Babette S. Heyer,Robert M. Kay,Allyn Kerchner,Philip Albert Leighton,Christine Mather,Sherie L. Morrison,Zivko L. Nikolov,David Passmore,Alicia Pradas-Monne,Benjamin T. Preston,Vangipuram S. Rangan,Mingxia Shi,Mohan Srinivasan,Steven G. White,Peggy Winters-Digiacinto,Susan Wong,Wen Zhou,Robert J. Etches +28 more
TL;DR: The ability of upstream and downstream DNA sequences of ovalbumin, a protein produced exclusively in very high quantities in chicken egg white, to drive tissue-specific expression of human mAb in chicken eggs is examined.